Biblio
Export 1914 results:
Author Title Type [ Year] Filters: First Letter Of Last Name is B [Clear All Filters]
“Pelargonidin and Berry Intake Association with Alzheimer's Disease Neuropathology: A Community-Based Study.”, J Alzheimers Dis, vol. 88, no. 2, pp. 653-661, 2022.
, “Plasma Amyloid and in vivo Brain Amyloid in Late Middle-Aged Hispanics.”, J Alzheimers Dis, vol. 87, no. 3, pp. 1229-1238, 2022.
, “Precision Medicine Approach to Alzheimer's Disease: Successful Pilot Project.”, J Alzheimers Dis, vol. 88, no. 4, pp. 1411-1421, 2022.
, “Precision Medicine Approach to Alzheimer's Disease: Successful Pilot Project.”, J Alzheimers Dis, vol. 88, no. 4, pp. 1411-1421, 2022.
, “Pre-Diagnostic Symptoms of Young-Onset Dementia in the General Practice up to Five Years Before Diagnosis.”, J Alzheimers Dis, vol. 88, no. 1, pp. 229-239, 2022.
, “Proteomic Profiles of Neurodegeneration Among Mexican Americans and Non-Hispanic Whites in the HABS-HD Study.”, J Alzheimers Dis, vol. 86, no. 3, pp. 1243-1254, 2022.
, “Psychosis as a Treatment Target in Dementia: A Roadmap for Designing Interventions.”, J Alzheimers Dis, vol. 88, no. 4, pp. 1203-1228, 2022.
, “Psychosis as a Treatment Target in Dementia: A Roadmap for Designing Interventions.”, J Alzheimers Dis, vol. 88, no. 4, pp. 1203-1228, 2022.
, “Risk of Alzheimer's Disease Following Influenza Vaccination: A Claims-Based Cohort Study Using Propensity Score Matching.”, J Alzheimers Dis, vol. 88, no. 3, pp. 1061-1074, 2022.
, “The Role of Amyloid-β, Tau, and α-Synuclein Proteins as Putative Blood Biomarkers in Patients with Cerebral Amyloid Angiopathy.”, J Alzheimers Dis, vol. 89, no. 3, pp. 1039-1049, 2022.
, “Safety and Efficacy of Monoclonal Antibodies for Alzheimer's Disease: A Systematic Review and Meta-Analysis of Published and Unpublished Clinical Trials.”, J Alzheimers Dis, vol. 87, no. 1, pp. 101-129, 2022.
, “Safety and Efficacy of Monoclonal Antibodies for Alzheimer's Disease: A Systematic Review and Meta-Analysis of Published and Unpublished Clinical Trials.”, J Alzheimers Dis, vol. 87, no. 1, pp. 101-129, 2022.
, “Salivary Proteomics Reveals Significant Changes in Relation to Alzheimer's Disease and Aging.”, J Alzheimers Dis, vol. 89, no. 2, pp. 605-622, 2022.
, “Sex-Specific Patterns of Body Mass Index Relationship with White Matter Connectivity.”, J Alzheimers Dis, vol. 86, no. 4, pp. 1831-1848, 2022.
, “Shortening of Saccades as a Possible Easy-to-Use Biomarker to Detect Risk of Alzheimer's Disease.”, J Alzheimers Dis, vol. 88, no. 2, pp. 609-618, 2022.
, “Single Nucleus Transcriptome Data from Alzheimer's Disease Mouse Models Yield New Insight into Pathophysiology.”, J Alzheimers Dis, vol. 90, no. 3, pp. 1233-1247, 2022.
, “Small RNA Sequencing in the Tg4-42 Mouse Model Suggests the Involvement of snoRNAs in the Etiology of Alzheimer's Disease.”, J Alzheimers Dis, vol. 87, no. 4, pp. 1671-1681, 2022.
, “Small RNA Sequencing in the Tg4-42 Mouse Model Suggests the Involvement of snoRNAs in the Etiology of Alzheimer's Disease.”, J Alzheimers Dis, vol. 87, no. 4, pp. 1671-1681, 2022.
, “Supplementation With Carotenoids, Omega-3 Fatty Acids, and Vitamin E Has a Positive Effect on the Symptoms and Progression of Alzheimer's Disease.”, J Alzheimers Dis, vol. 90, no. 1, pp. 233-249, 2022.
, “Transcriptome and Translatome Regulation of Pathogenesis in Alzheimer's Disease Model Mice.”, J Alzheimers Dis, vol. 86, no. 1, pp. 365-386, 2022.
, “Traumatic Brain Injury and Risk of Alzheimer's Disease and Related Dementias in the Population.”, J Alzheimers Dis, vol. 88, no. 3, pp. 1049-1059, 2022.
, “Visually Identified Tau 18F-MK6240 PET Patterns in Symptomatic Alzheimer's Disease.”, J Alzheimers Dis, vol. 88, no. 4, pp. 1627-1637, 2022.
, “Visually Identified Tau 18F-MK6240 PET Patterns in Symptomatic Alzheimer's Disease.”, J Alzheimers Dis, vol. 88, no. 4, pp. 1627-1637, 2022.
, “Visually Identified Tau 18F-MK6240 PET Patterns in Symptomatic Alzheimer's Disease.”, J Alzheimers Dis, vol. 88, no. 4, pp. 1627-1637, 2022.
, “Accelerometer-Measured, Habitual Physical Activity and Circulating Brain-Derived Neurotrophic Factor: A Cross-Sectional Study.”, J Alzheimers Dis, vol. 85, no. 2, pp. 805-814, 2021.
,